Biosimilar Denosumab

denosumab · Enzene Biosciences Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Biosimilar Denosumab, covering 2026-02-10 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study to Compare Biosimilar Denosumab With Prolia® [Phase 3]